CN113717927B - 一种hek-293细胞无血清和悬浮培养的制备方法及其应用 - Google Patents
一种hek-293细胞无血清和悬浮培养的制备方法及其应用 Download PDFInfo
- Publication number
- CN113717927B CN113717927B CN202111014696.XA CN202111014696A CN113717927B CN 113717927 B CN113717927 B CN 113717927B CN 202111014696 A CN202111014696 A CN 202111014696A CN 113717927 B CN113717927 B CN 113717927B
- Authority
- CN
- China
- Prior art keywords
- cells
- cell
- serum
- medium
- culture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000004114 suspension culture Methods 0.000 title claims abstract description 17
- 238000002360 preparation method Methods 0.000 title abstract description 17
- 239000000725 suspension Substances 0.000 claims description 52
- 210000002966 serum Anatomy 0.000 claims description 38
- 239000002609 medium Substances 0.000 claims description 37
- 238000012258 culturing Methods 0.000 claims description 25
- 241000700605 Viruses Species 0.000 claims description 20
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 claims description 15
- 230000003247 decreasing effect Effects 0.000 claims description 13
- 238000007710 freezing Methods 0.000 claims description 13
- 230000008014 freezing Effects 0.000 claims description 13
- 238000000034 method Methods 0.000 claims description 11
- 108090000623 proteins and genes Proteins 0.000 claims description 10
- 239000001963 growth medium Substances 0.000 claims description 8
- 238000004519 manufacturing process Methods 0.000 claims description 7
- 230000007423 decrease Effects 0.000 claims description 6
- 238000012216 screening Methods 0.000 claims description 5
- 238000004806 packaging method and process Methods 0.000 claims description 3
- 102000004169 proteins and genes Human genes 0.000 claims description 3
- 230000012010 growth Effects 0.000 abstract description 10
- 238000011031 large-scale manufacturing process Methods 0.000 abstract description 6
- 230000008901 benefit Effects 0.000 abstract description 5
- 230000004083 survival effect Effects 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 192
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 20
- 239000012091 fetal bovine serum Substances 0.000 description 20
- 238000001890 transfection Methods 0.000 description 16
- 230000000694 effects Effects 0.000 description 14
- 239000006228 supernatant Substances 0.000 description 12
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 10
- 230000010261 cell growth Effects 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- 230000001464 adherent effect Effects 0.000 description 8
- 238000004113 cell culture Methods 0.000 description 8
- 239000006143 cell culture medium Substances 0.000 description 7
- 238000002156 mixing Methods 0.000 description 7
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- 230000007910 cell fusion Effects 0.000 description 6
- 239000004017 serum-free culture medium Substances 0.000 description 6
- 239000007788 liquid Substances 0.000 description 5
- 229910052757 nitrogen Inorganic materials 0.000 description 5
- 238000007664 blowing Methods 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 239000012737 fresh medium Substances 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- 238000003860 storage Methods 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 241000713666 Lentivirus Species 0.000 description 3
- 238000005054 agglomeration Methods 0.000 description 3
- 230000002776 aggregation Effects 0.000 description 3
- 210000000805 cytoplasm Anatomy 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- 239000013612 plasmid Substances 0.000 description 3
- 238000001556 precipitation Methods 0.000 description 3
- 239000011550 stock solution Substances 0.000 description 3
- 230000004663 cell proliferation Effects 0.000 description 2
- 239000006285 cell suspension Substances 0.000 description 2
- 238000005138 cryopreservation Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 239000012595 freezing medium Substances 0.000 description 2
- 210000003292 kidney cell Anatomy 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000013598 vector Substances 0.000 description 2
- 108010077544 Chromatin Proteins 0.000 description 1
- 108010066154 Nuclear Export Signals Proteins 0.000 description 1
- 238000012228 RNA interference-mediated gene silencing Methods 0.000 description 1
- 108010052164 Sodium Channels Proteins 0.000 description 1
- 102000018674 Sodium Channels Human genes 0.000 description 1
- 239000007640 basal medium Substances 0.000 description 1
- 238000010009 beating Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 210000003483 chromatin Anatomy 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000009368 gene silencing by RNA Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000004264 monolayer culture Methods 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 238000007427 paired t-test Methods 0.000 description 1
- 239000013618 particulate matter Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000010079 rubber tapping Methods 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 239000012679 serum free medium Substances 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000011870 unpaired t-test Methods 0.000 description 1
- 239000013603 viral vector Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0684—Cells of the urinary tract or kidneys
- C12N5/0686—Kidney cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Urology & Nephrology (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
样品名称 | 24h转染效率 | TU滴度 |
LV-GFP-293XS | 86.4% | 9.68×10<sup>6</sup> |
LV-GFP-293F | 31.3% | 4.65×10<sup>5</sup> |
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111014696.XA CN113717927B (zh) | 2021-08-31 | 2021-08-31 | 一种hek-293细胞无血清和悬浮培养的制备方法及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111014696.XA CN113717927B (zh) | 2021-08-31 | 2021-08-31 | 一种hek-293细胞无血清和悬浮培养的制备方法及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113717927A CN113717927A (zh) | 2021-11-30 |
CN113717927B true CN113717927B (zh) | 2022-11-18 |
Family
ID=78679950
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111014696.XA Active CN113717927B (zh) | 2021-08-31 | 2021-08-31 | 一种hek-293细胞无血清和悬浮培养的制备方法及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113717927B (zh) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115505559A (zh) * | 2022-09-30 | 2022-12-23 | 苏州博腾生物制药有限公司 | 用于病毒载体生产的hek293悬浮细胞系的开发方法 |
CN114395522B (zh) * | 2021-12-23 | 2023-06-09 | 宜明(苏州)细胞生物科技有限公司 | 一种hek293t细胞悬浮和无血清培养的快速驯化方法及其应用 |
CN114591889A (zh) * | 2022-04-06 | 2022-06-07 | 湖南远泰生物技术有限公司 | 一种hek293t细胞的悬浮驯化方法及其在慢病毒生产中的应用 |
CN115747137B (zh) * | 2022-11-07 | 2024-03-08 | 青岛万明赛伯药业有限公司 | Hek293单克隆细胞群的培养方法 |
CN116970547B (zh) * | 2023-02-24 | 2024-04-09 | 广州恩宝生物医药科技有限公司 | 一种驯化无血清全悬浮hek293细胞的方法及其应用 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113604425A (zh) * | 2021-06-22 | 2021-11-05 | 中山康天晟合生物技术有限公司 | 一种适应无血清培养基环境的wayne293 lvpro细胞及其应用 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2551026A1 (en) * | 2003-12-23 | 2005-07-14 | Schering Corporation | Methods for producing a549 cell lines stable in serum-free medium suspension culture |
CN102604889B (zh) * | 2012-03-19 | 2013-05-08 | 中国农业科学院哈尔滨兽医研究所 | 适应无血清培养的hek293细胞系及其应用 |
CN108865967A (zh) * | 2017-05-11 | 2018-11-23 | 华威特(江苏)生物制药有限公司 | 一种快速驯化贴壁细胞为全悬浮细胞系的方法 |
CN109280636A (zh) * | 2017-07-21 | 2019-01-29 | 上海恒润达生生物科技有限公司 | 一种悬浮驯化293t细胞的方法 |
CN110713971B (zh) * | 2019-11-06 | 2021-08-27 | 深圳市菲鹏生物治疗股份有限公司 | 一种无血清悬浮培养型293t细胞、其制备方法以及病毒的包装方法 |
-
2021
- 2021-08-31 CN CN202111014696.XA patent/CN113717927B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113604425A (zh) * | 2021-06-22 | 2021-11-05 | 中山康天晟合生物技术有限公司 | 一种适应无血清培养基环境的wayne293 lvpro细胞及其应用 |
Non-Patent Citations (1)
Title |
---|
"Development and improvement of a serum-free suspension process for the production of recombinant adenoviral vectors using HEK293 cells";Yung-Shyeng Tsao等;《Cytotechnology》;20011130;第37卷(第3期);摘要,第190页左栏最后1段-第191页第1段,第192页右栏第2段-第193页左栏第1段,图1,2 * |
Also Published As
Publication number | Publication date |
---|---|
CN113717927A (zh) | 2021-11-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN113717927B (zh) | 一种hek-293细胞无血清和悬浮培养的制备方法及其应用 | |
JP6758659B2 (ja) | 揺動プラットフォームバイオリアクターを用いた多能性幹細胞の増殖及び継代 | |
KR20170076679A (ko) | 파종 밀도 한계를 증가시키고 원하는 팽창 시간을 감소시키는 접착 세포 생물반응기에의 비접착세포의 파종 | |
JP2008067720A (ja) | 細胞培養およびウイルス増殖のための方法 | |
WO2013109520A1 (en) | Perfusion bioreactor systems and methods of operating the same | |
CN113604425A (zh) | 一种适应无血清培养基环境的wayne293 lvpro细胞及其应用 | |
CN111154713B (zh) | 人胚肾上皮细胞293T-Clone3单克隆细胞株及其应用 | |
CN108570445A (zh) | Pk15细胞驯化悬浮方法和二阶病毒生产工艺 | |
CN115386530A (zh) | 植物叶片原生质体的快速制备和转化方法、试剂盒及应用 | |
CN108607101A (zh) | Zip1基因在制备抑制骨髓间充质干细胞凋亡的产品中的应用 | |
CN112094814A (zh) | 一种通过灌流培养工艺制备腺病毒载体疫苗的方法 | |
CN114736855B (zh) | 一种干细胞外泌体高纯度提取方法 | |
CN108753703B (zh) | 一种牙鲆胚胎肌卫星细胞系建立方法 | |
WO2022260149A1 (ja) | 低温管理された細胞凝集塊及び細胞凝集塊の維持方法 | |
CN115386531A (zh) | 植物通用型原生质体制备和瞬时转化方法、试剂盒及应用 | |
CN114836367A (zh) | 用于hek293细胞培养及腺病毒、腺相关病毒复制扩增的化学成分限定培养基 | |
CN108660108A (zh) | 一种可增强脐带间充质干细胞免疫调节能力的方法 | |
CN111378621B (zh) | Eb病毒潜伏期膜蛋白1稳定转染的b淋巴瘤细胞株、其构建方法和应用 | |
CN109266683B (zh) | 一种包含e4bp4基因的慢病毒重组载体及其制备方法和应用 | |
RU2488631C1 (ru) | ЛИНИЯ КЛЕТОК ПОЧКИ ТЕЛЕНКА Bos taurus RBT (Rene Bos Taurus) ДЛЯ РЕПРОДУКЦИИ ВИРУСОВ ЖИВОТНЫХ | |
CN111718889A (zh) | 一种Sf9细胞的无血清全悬浮驯化方法 | |
CN106676071B (zh) | HeLa-F细胞及其用途 | |
CN109852637B (zh) | 一种提高腺相关病毒转染效率的方法 | |
CN111019881B (zh) | 一种适应高渗透压、高铵离子、高乳酸生长环境的细胞 | |
CN115948334B (zh) | 一株鳜鱼脑细胞克隆细胞株及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20230522 Address after: 310 / 312, floor 3, building 1, No. 538, yongfengtun, Haidian District, Beijing 100094 Patentee after: Yiming (Beijing) Cell Biotechnology Co.,Ltd. Patentee after: Yiming (Suzhou) Cell Biotechnology Co.,Ltd. Patentee after: Jinan Yiming Medical Technology Co.,Ltd. Address before: 310 / 312, floor 3, building 1, No. 538, yongfengtun, Haidian District, Beijing 100094 Patentee before: Yiming (Beijing) Cell Biotechnology Co.,Ltd. |
|
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: 310 / 312, floor 3, building 1, No. 538, yongfengtun, Haidian District, Beijing 100094 Patentee after: Jiangsu Yiming Biotechnology Co.,Ltd. Patentee after: Yiming (Suzhou) Cell Biotechnology Co.,Ltd. Patentee after: Yiming (Jinan) Biotechnology Co.,Ltd. Address before: 310 / 312, floor 3, building 1, No. 538, yongfengtun, Haidian District, Beijing 100094 Patentee before: Yiming (Beijing) Cell Biotechnology Co.,Ltd. Patentee before: Yiming (Suzhou) Cell Biotechnology Co.,Ltd. Patentee before: Jinan Yiming Medical Technology Co.,Ltd. |